These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 9625124

  • 1. Nocturnal recovery of gastric acid secretion with twice-daily dosing of proton pump inhibitors.
    Peghini PL, Katz PO, Bracy NA, Castell DO.
    Am J Gastroenterol; 1998 May; 93(5):763-7. PubMed ID: 9625124
    [Abstract] [Full Text] [Related]

  • 2. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy.
    Leite LP, Johnston BT, Just RJ, Castell DO.
    Am J Gastroenterol; 1996 Aug; 91(8):1527-31. PubMed ID: 8759655
    [Abstract] [Full Text] [Related]

  • 3. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole.
    Katz PO, Hatlebakk JG, Castell DO.
    Aliment Pharmacol Ther; 2000 Jun; 14(6):709-14. PubMed ID: 10848653
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms.
    Katz PO, Koch FK, Ballard ED, Bagin RG, Gautille TC, Checani GC, Hogan DL, Pratha VS.
    Aliment Pharmacol Ther; 2007 Jan 15; 25(2):197-205. PubMed ID: 17229243
    [Abstract] [Full Text] [Related]

  • 5. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A, Celikel CA, Ozdogan O, Tözün N, Ulusoy NB, Kalayci C.
    J Gastroenterol Hepatol; 2005 Dec 15; 20(12):1886-91. PubMed ID: 16336449
    [Abstract] [Full Text] [Related]

  • 6. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
    Mainie I, Tutuian R, Castell DO.
    J Clin Gastroenterol; 2008 Jul 15; 42(6):676-9. PubMed ID: 18496394
    [Abstract] [Full Text] [Related]

  • 7. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
    Moretzsohn LD, Carvalho EB, Franco JD, Soares MP, Brito EM, Belarmino K, Coelho LG.
    Can J Clin Pharmacol; 2009 Jul 15; 16(1):e264-72. PubMed ID: 19383986
    [Abstract] [Full Text] [Related]

  • 8. Effect of omeprazole on acid gastroesophageal reflux and gastric acidity in preterm infants with pathological acid reflux.
    Omari TI, Haslam RR, Lundborg P, Davidson GP.
    J Pediatr Gastroenterol Nutr; 2007 Jan 15; 44(1):41-4. PubMed ID: 17204951
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease.
    Castell D, Bagin R, Goldlust B, Major J, Hepburn B.
    Aliment Pharmacol Ther; 2005 Jun 15; 21(12):1467-74. PubMed ID: 15948814
    [Abstract] [Full Text] [Related]

  • 10. Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment.
    Miner PB, Allgood LD, Grender JM.
    Aliment Pharmacol Ther; 2007 Jan 01; 25(1):103-9. PubMed ID: 17229225
    [Abstract] [Full Text] [Related]

  • 11. Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors.
    Katz PO, Anderson C, Khoury R, Castell DO.
    Aliment Pharmacol Ther; 1998 Dec 01; 12(12):1231-4. PubMed ID: 9882031
    [Abstract] [Full Text] [Related]

  • 12. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J, Kandulski A, Büsch F, Malfertheiner P.
    Dig Dis; 2009 Dec 01; 27(1):68-73. PubMed ID: 19439964
    [Abstract] [Full Text] [Related]

  • 13. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ, Hunt RH.
    Yale J Biol Med; 1999 Dec 01; 72(2-3):181-94. PubMed ID: 10780580
    [Abstract] [Full Text] [Related]

  • 14. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
    Park W, Hicks DM, Khandwala F, Richter JE, Abelson TI, Milstein C, Vaezi MF.
    Laryngoscope; 2005 Jul 01; 115(7):1230-8. PubMed ID: 15995512
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ, Hunt RH.
    Best Pract Res Clin Gastroenterol; 2001 Jun 01; 15(3):355-70. PubMed ID: 11403532
    [Abstract] [Full Text] [Related]

  • 16. Frequency analyses of gastric pH in control and gastro-oesophageal reflux disease subjects treated with a proton-pump inhibitor.
    Gardner JD, Sloan S, Robinson M, Miner PB.
    Aliment Pharmacol Ther; 2004 Dec 01; 20(11-12):1381-6. PubMed ID: 15606401
    [Abstract] [Full Text] [Related]

  • 17. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
    Janiak P, Thumshirn M, Menne D, Fox M, Halim S, Fried M, Brühlmann P, Distler O, Schwizer W.
    Aliment Pharmacol Ther; 2007 Nov 01; 26(9):1259-65. PubMed ID: 17944740
    [Abstract] [Full Text] [Related]

  • 18. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
    Pfefferkorn MD, Croffie JM, Gupta SK, Molleston JP, Eckert GJ, Corkins MR, Fitzgerald JF.
    J Pediatr Gastroenterol Nutr; 2006 Feb 01; 42(2):160-5. PubMed ID: 16456408
    [Abstract] [Full Text] [Related]

  • 19. An evaluation of the clinical implications of acid breakthrough in patients on proton pump inhibitor therapy.
    Nzeako UC, Murray JA.
    Aliment Pharmacol Ther; 2002 Jul 01; 16(7):1309-16. PubMed ID: 12144581
    [Abstract] [Full Text] [Related]

  • 20. Control of 24-hour intragastric acidity with morning dosing of immediate-release and delayed-release proton pump inhibitors in patients with GERD.
    Howden CW, Ballard ED, Koch FK, Gautille TC, Bagin RG.
    J Clin Gastroenterol; 2009 Apr 01; 43(4):323-6. PubMed ID: 18758373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.